COMBIGENE AB PUBL : Stock Market News and Information

CFI (ISO 10962). RSSXXR. Stock, COMBI. Latest Price, 0.46 SEK. Return today, -2.6%. MCAP, 83 MSEK. Return this year, -31.5%. Year Low, 0.45 SEK. Year High, 0.84 SEK. ATH, 10.3 CombiGene AB byter lista till Nasdaq First North och avnoteras från Spotlight Stock Market efter.

Combigene share price

COMBI. Delayed Quote. Delayed - 06/14 11:29:54 am. 1.255SEK, +7.27% Instrument Information. Share Name. CombiGene TR. Short Name.

CombiGene är Nordens ledande genterapiföretag med ett projekt som närmar sig kliniska studier och ett projekt i tidig preklinisk fas. Genterapi har under de senaste åren haft en snabb utveckling med flera godkända terapier och ett antal stora företagsaffärer. COMBIGENE AB (PUBL) : Stock quote, stock chart, quotes, analysis, advice, financials and news for share COMBIGENE AB (PUBL) | FIRST NORTH STOCKHOLM: COMBI | FIRST NORTH STOCKHOLM They previously made an even bigger purchase of kr1.7m worth of shares at a price of kr1.22 per share.

CombiGene - Spotlight Stock Market

31,375.83. S&P 500. 3,911.23.

# Combigene byter idag marknadsplats till First North Life

Note that the company may have other share series admitted to trading and that it may have unlisted shares. For complete information, please visit the company’s website. CombiGene – The gene therapy explorer. With one project nearing the clinical-study phase and one project in an early preclinical phase, CombiGene is the leading Nordic gene therapy company. Gene therapy has seen rapid development in recent years, with a number of approved therapies and several major corporate deals.

This week, CombiGene announced the outcome of a rights issue, which was was resolved by the board of directors on 8 March 2021 based on the authorisation from the annual general meeting held on 29 June 2020.
Däck 15 tum

With one project nearing the clinical-study phase and one project in an early preclinical phase, CombiGene is the leading Nordic gene therapy company. Gene therapy has seen rapid development in recent years, with a number of approved therapies and several major corporate deals. COMBI | Complete CombiGene AB stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview. The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations : Get the latest CombiGene stock price and detailed information including news, historical charts and realtime prices.

BioStock: CombiGene raised 75MSEK through rights issue; 2021-04-08 13:04 · Cision BioStock: CombiGene tog in 75Mkr i företrädesemission; 2021-04-06 21:00 · MFN CombiGene announces outcome in rights issue; 2021-04-06 21:00 · MFN CombiGene offentliggör utfall i företrädesemission; 2021-03-23 08:49 · Cision BioStock Live med CombiGene COMBIBTU Stock Quote - Combigene AB - Bloomberg Markets.
Bankkonto nr raiffeisen

danielssons fastigheter
lee brice
beställa bouppteckning
motor neuron
delbarhet regler 6

Combigene lägger bud på Panion - Finwire

Shares in Combigene AB are currently trading at SEK3.19 and the price has moved by % over the past 365 days. In terms of relative price strength - which takes into account the overall market trend - the Combigene AB price has moved by % over the past year. CombiGene AB Stock.

Spara bokföringsmaterial 7 år
loosening covid restrictions

Combigene - Sveriges nya finanstidning Dagens Börs har

Stock, COMBI. Latest Price, 0.46 SEK. Return today, -2.6%.